[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633374":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":100,"collaborators":102,"id":105,"slug":106,"hasResults":107,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":24,"eligibilityCriteria":111,"healthyVolunteers":107,"sex":112,"minAge":113,"maxAge":24,"enrollmentInfo":114,"targetDuration":24,"studyType":117,"phases":118,"briefSummary":120,"conditions":121,"keywords":123,"overallStatus":130,"whyStopped":24,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":135,"completionDateStruct":137,"leadSponsor":139,"locationsCount":140},{"fullName":5,"class":6},"CHU de Quebec-Universite Laval","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Immediate intervention (for 16 months)","EXPERIMENTAL","The intervention includes nurse-led remote self-monitoring of RA, with patients completing monthly self-assessments of disease activity (RADAI), symptoms and function (PROMIS-29). Rheumatology nurses will receive alerts if monitoring suggests moderate\u002Fhigh disease activity and will contact participants to determine care needed. Tailored information based on PROMIS-29 answers will be sent to facilitate self-management. Asynchronous messaging with rheumatology nurses and information on RA self-management will be available.",[13],"Other: Nurse-led telehealth remote self-monitoring",{"label":15,"type":16,"description":17,"interventionNames":18},"Delayed intervention ( 8 months of control period followed by 8 months with the intervention)","ACTIVE_COMPARATOR","Usual care for 8 months, consisting in rheumatology visits scheduled every 3-6 months.\n\nFollowed by the intervention for 8 months: The intervention includes nurse-led remote self-monitoring of RA, with patients completing monthly self-assessments of disease activity (RADAI), symptoms and function (PROMIS-29). Rheumatology nurses will receive alerts if monitoring suggests moderate\u002Fhigh disease activity and will contact participants to determine care needed. Tailored information based on PROMIS-29 answers will be sent to facilitate self-management. Asynchronous messaging with rheumatology nurses and information on RA self-management will be available.",[13],[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Nurse-led telehealth remote self-monitoring","Remote self-monitoring will use a web platform co-developed with patients, rheumatologists, and nurses. The intervention includes nurse-led remote self-monitoring of RA, with patients completing monthly self-assessments of disease activity (RADAI), symptoms and function (PROMIS-29). Rheumatology nurses will receive alerts if monitoring suggests moderate\u002Fhigh disease activity and will contact participants to determine care needed. Tailored information based on PROMIS-29 answers will be sent to facilitate self-management. Asynchronous messaging with rheumatology nurses and information on RA self-management will be available.",[15,9],null,[26],{"name":27,"affiliation":5,"role":28},"Laetitia Michou, MD PhD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","+14185254444","48383","laetitia.michou@crchudequebec.ulaval.ca",[36,56,73,81],{"facility":37,"status":24,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Hopital general de Montreal","Montreal","Quebec","H3H 1V6","Canada","CA",{"type":44,"coordinates":45},"Point",[46,47],-73.58781,45.50884,{"lat":47,"lon":46},[50,55],{"name":51,"role":31,"phone":52,"phoneExt":53,"email":54},"Ines Colmegna, MD","+1 (514) 934-1934","35639","ines.colmegna@mcgill.ca",{"name":51,"role":28,"phone":24,"phoneExt":24,"email":24},{"facility":57,"status":24,"city":58,"state":39,"zip":59,"country":41,"countryCode":42,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Centre de l'ostéporose et de rhumatologie de Québec","Québec","G1V 2M1",{"type":44,"coordinates":61},[62,63],-71.21454,46.81228,{"lat":63,"lon":62},[66,70,72],{"name":67,"role":31,"phone":68,"phoneExt":24,"email":69},"Louis Bessette, MD","+1 418-650-0698","louis.bessette@crchudequebec.ulaval.ca",{"name":67,"role":31,"phone":71,"phoneExt":24,"email":69},"+ 1 418-650-0698",{"name":67,"role":28,"phone":24,"phoneExt":24,"email":24},{"facility":5,"status":24,"city":58,"state":39,"zip":74,"country":41,"countryCode":42,"cosmosGeoPoint":75,"geoPoint":77,"contacts":78},"G1V4G2",{"type":44,"coordinates":76},[62,63],{"lat":63,"lon":62},[79,80],{"name":27,"role":31,"phone":32,"phoneExt":33,"email":34},{"name":27,"role":28,"phone":24,"phoneExt":24,"email":24},{"facility":82,"status":24,"city":83,"state":39,"zip":84,"country":41,"countryCode":42,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Hopital Fleurimont et Hotel Dieu de Sherbrooke","Sherbrooke","J1H 5H3",{"type":44,"coordinates":86},[87,88],-71.89908,45.40008,{"lat":88,"lon":87},[91,96,97],{"name":92,"role":31,"phone":93,"phoneExt":94,"email":95},"Hugues Allard-Chamard, MD","+1 819 821-8000","15261","hugues.allard-chamard@usherbrooke.ca",{"name":92,"role":28,"phone":24,"phoneExt":24,"email":24},{"name":98,"role":99,"phone":24,"phoneExt":24,"email":24},"Javier Marrugo, MD","SUB_INVESTIGATOR",{"type":101,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[103],{"name":104,"class":6},"The Arthritis Society, Canada","100633374","acceptability-of-a-nurse-led-telehealth-remote-self-monitoring-model-of-care-in-patients-with-rheumatoid-arthritis-100633374",false,"NCT07525856","Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis","Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis, a Multicentre Randomized Pilot Study","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of rheumatoid arthritis (RA) according to the ACR 2010 criteria\n* Disease duration ≥ six months\n* Who experienced a flare defined by an increase of the clinical disease activity index (CDAI) ≥ 4.5 or a DMARDs switch or addition within the preceding three months\n* Understanding French or English\n\nExclusion Criteria:\n\n* Inability to consent\n* Inability to complete questionnaires\n* No Internet access","ALL","18 Years",{"count":115,"type":116},104,"ESTIMATED","INTERVENTIONAL",[119],"NA","Canada urgently needs new ways to provide rheumatology care that improve treatment and make it easier for people to get high-quality care. E-health technology is a new and promising way to do this, but it hasn't been studied much yet in rheumatology.\n\nThe investigators will test a new way to help people with rheumatoid arthritis at four clinics in Quebec. This study will check if the new approach is easy to use, fits well into the clinics' daily routine, and if both patients and healthcare workers find it helpful and acceptable.\n\nThis new approach involves nurses helping patients check their own health from home using an online platform.\n\n104 adults who have rheumatoid arthritis and who have had a flare-up or a change in their medication in the last three months, will participate. Some will start using the online self-monitoring tool right away for 16 months, while others will continue with their usual care for 8 months before trying the tool. During the time they use the tool, they will fill out monthly online questionnaires to check their health. A rheumatology nurse will review their answers, suggest any needed care, provide personalized health information, and be available to answer questions through messages.\n\nThis new way of care, where nurses help patients monitor their rheumatoid arthritis from home, helps make better use of limited specialist time. It's more convenient for patients, especially those who live far away, and helps meet their needs between regular doctor visits while keeping the quality of care high.",[122],"Rheumatoid Arthritis (RA)",[124,125,126,127,128,129],"Arthritis activity remote self-monitoring","Nurse-led telehealth intervention","Pilot randomised trial","Self-assessment of disease activity","RE-AIM implementation framework","Semi-structured interviews","NOT_YET_RECRUITING","2026-04-07",{"date":133,"type":134},"2026-04-13","ACTUAL",{"date":136,"type":116},"2026-05",{"date":138,"type":116},"2027-12",{"name":5,"class":6},4]